ATXN3 and Spinocerebellar ataxia type 3: Furthermore, studies employing immunofluorescence techniques and magnetic resonance dynamic contrast enhancement assessment in SCA3 transgenic mouse models have demonstrated blood-brain barrier disruption, a finding corroborated in postmortem brain samples from SCA3 patients [34].